At 7 months of age, a significant upregulation of Ms4a4a was observed in the cerebral cortex, hippocampus, thalamus, and hypothalamus of APP/PS1 mice compared to WT mice, during the progressive phase of AD pathology (Figure1A). This evidence concerns the gene MS4A4A and Alzheimer disease.